CISPLATIN INTAS cisplatin 10 mg/10 mL concentrated injection vial

País: Austrália

Língua: inglês

Origem: Department of Health (Therapeutic Goods Administration)

Ingredientes ativos:

cisplatin, Quantity: 1 mg/mL

Disponível em:

Accord Healthcare Pty Ltd

Forma farmacêutica:

Injection, concentrated

Composição:

Excipient Ingredients: sodium chloride; water for injections; hydrochloric acid; sodium hydroxide

Via de administração:

Intravenous

Unidades em pacote:

1

Tipo de prescrição:

(S4) Prescription Only Medicine

Indicações terapêuticas:

Cisplatin Intas may be used as a monotherapy or in combination with other chemotherapeutic agents in the treatment of:,? Metastatic non-seminomatous germ cell carcinomama,? Advanced stage, refractory ovarian carcinoma,? Advanced stage, refractory bladder carcinoma,? Refractory squamous cell carcinoma of the head and neck

Resumo do produto:

Visual Identification: A clear, colourless to pale yellow solution in an amber glass vial; Container Type: Vial; Container Material: Glass Type I Coloured; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius

Status de autorização:

Registered

Data de autorização:

2018-07-09